Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Carter · SciRah

Researcher profile · Semantic Scholar

T. Carter

Share profile

T. Carter — researcher profile on SciRah

h-index: 21
Works: 50
Citations: 3,663

Most-cited papers

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
G. Marcucci, K. Maharry, Yue-Zhong Wu, M. Radmacher +16 more
2010Journal of Clinical Oncology782 citations Open access
Semantic Scholar
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.
H. Becker, G. Marcucci, K. Maharry, M. Radmacher +15 more
2010Journal of Clinical Oncology362 citations Open access
Semantic Scholar
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.
K. Metzeler, K. Maharry, M. Radmacher, K. Mrózek +19 more
2011Journal of Clinical Oncology347 citations Open access
Semantic Scholar
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.
K. Metzeler, H. Becker, K. Maharry, M. Radmacher +17 more
2011Blood291 citations Open access
Semantic Scholar
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.
Jason H. Mendler, K. Maharry, M. Radmacher, K. Mrózek +18 more
2012Journal of Clinical Oncology281 citations Open access
Semantic Scholar
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.
G. Marcucci, K. Metzeler, S. Schwind, H. Becker +17 more
2012Journal of Clinical Oncology241 citations Open access
Semantic Scholar
Expression and prognostic impact of lncRNAs in acute myeloid leukemia
R. Garzon, S. Volinia, D. Papaioannou, D. Nicolet +20 more
2014Proceedings of the National Academy of Sciences of the United States of America237 citations Open access
Semantic Scholar
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
S. Whitman, K. Maharry, M. Radmacher, H. Becker +19 more
2010Blood234 citations Open access
Semantic Scholar
Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score.
G. Marcucci, P. Yan, K. Maharry, D. Frankhouser +27 more
2014Journal of Clinical Oncology151 citations Open access
Semantic Scholar
BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
S. Schwind, G. Marcucci, K. Maharry, M. Radmacher +16 more
2010Blood114 citations Open access
Semantic Scholar
A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia
A. Schimmer, A. Raza, T. Carter, D. Claxton +5 more
2014PLoS ONE77 citations Open access
Semantic Scholar
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia
Christian Niederwieser, J. Kohlschmidt, S. Volinia, S. Whitman +23 more
2014Leukemia77 citations Open access
Semantic Scholar
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.
Ann-Kathrin Eisfeld, G. Marcucci, K. Maharry, S. Schwind +21 more
2012Blood68 citations Open access
Semantic Scholar
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia
K. Metzeler, K. Maharry, J. Kohlschmidt, S. Volinia +18 more
2013Leukemia60 citations Open access
Semantic Scholar
A phase III randomized trial of intensive induction and consolidation chemotherapy ± oblimersen, a pro-apoptotic Bcl-2 antisense oligonucleotide in untreated acute myeloid leukemia patients >60 years old
G. Marcucci, Barry K. Moser, W. Blum, W. Stock +6 more
200758 citations
Semantic Scholar
GAS6 expression identifies high-risk adult AML patients: potential implications for therapy
S. Whitman, J. Kohlschmidt, K. Maharry, S. Volinia +17 more
2013Leukemia56 citations Open access
Semantic Scholar
Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia
D. Papaioannou, Changxian Shen, D. Nicolet, B. McNeil +20 more
2017Proceedings of the National Academy of Sciences of the United States of America43 citations Open access
Semantic Scholar
A fatal case of West Nile virus infection in a bone marrow transplant recipient.
B. Hiatt, L. Desjardin, T. Carter, R. Gingrich +2 more
2003Clinical Infectious Diseases40 citations Open access
Semantic Scholar
Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8
H. Becker, K. Maharry, K. Mrózek, S. Volinia +20 more
2014Leukemia32 citations Open access
Semantic Scholar
Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
H. Becker, K. Maharry, M. Radmacher, K. Mrózek +16 more
2011Haematologica23 citations Open access
Semantic Scholar
The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia
SP Whitman, M. Caligiuri, K. Maharry, M. Radmacher +17 more
2012Leukemia22 citations Open access
Semantic Scholar
In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline
Jason H. Mendler, K. Maharry, H. Becker, Ann-Kathrin Eisfeld +13 more
2013Haematologica10 citations Open access
Semantic Scholar
Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease.
V. Roy, Lubna I. Ali, T. Carter, George B. Selby
2000Journal of Infection10 citations
Semantic Scholar
Mutations In the Tet Oncogene Family Member 2 (TET2) Gene Refine the New European LeukemiaNet Risk Classification of Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) In Adults: A Cancer and Leukemia Group B (CALGB) Study
K. Metzeler, K. Maharry, M. Radmacher, K. Mrózek +19 more
20109 citations
Semantic Scholar
A safety and schedule seeking trial of Bcl-2 inhibitor obatoclax in previously untreated older patients with acute myeloid leukemia (AML).
A. Raza, N. Galili, G. Borthakur, T. Carter +5 more
2009Journal of Clinical Oncology8 citations
Semantic Scholar
The influence of health insurance on outcomes of related-donor hematopoietic stem cell transplantation for AML and CML.
G. Selby, Lubna I. Ali, T. Carter, S. Veseley +1 more
2001Biology of Blood and Marrow Transplantation8 citations Open access
Semantic Scholar
Efficacy and safety of oral granisetron versus i.v. granisetron in patients undergoing peripheral blood progenitor cell and bone marrow transplantation
A. M. Abang, M. Takemoto, T. Pham, Romeo A. Mandanas +3 more
2000Anti-Cancer Drugs7 citations
Semantic Scholar
Hypomethylating Agents and Low-Dose Venetoclax for Relapse Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation
C. Vigil, M. Silverman, T. Carter
20204 citations Open access
Semantic Scholar
ASXL1 Mutations Identify a High-Risk Subgroup of Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia within the European LeukemiaNet ‘Favorable9 Genetic Category
K. Metzeler, H. Becker, K. Maharry, M. Radmacher +17 more
20113 citations
Semantic Scholar
Pilot Study of Lovastatin in Patients with Myelodysplastic Syndrome (MDS) Receiving Arsenic Trioxide (Trisenox®) Therapy.
Annemarie Stroh, T. Carter, R. Hohl, P. Zehr +1 more
20053 citations
Semantic Scholar
Clofarabine and Low-Dose Cytarabine Combination in Relapsed/Refractory Acute Myeloid Leukemia Patients with High Risk Features
C. Vigil, N. Jahan, Oana Păun, J. Weis +3 more
20172 citations
Semantic Scholar
miR-3151 Interplays With its Host Gene BAALC and Independently Impacts on Outcome of Older Patients With Cytogenetically Normal Acute Myeloid Leukemia by Direct Deregulation of TP53
Ann-Kathrin Eisfeld, G. Marcucci, K. Maharry, S. Schwind +21 more
20142 citations
Semantic Scholar
Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
H. Becker, G. Marcucci, K. Maharry, M. Radmacher +17 more
2010Blood2 citations Open access
Semantic Scholar
Adverse Prognostic Impact of GAS6 Expression in De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (CALGB 8461, 9665, 20202; Alliance)
S. Whitman, J. Kohlschmidt, K. Maharry, D. Nicolet +15 more
20121 citations
Semantic Scholar
Poor Outcome of RUNX1-Mutated (RUNX1-mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures,
Jason H. Mendler, K. Maharry, M. Radmacher, K. Mrózek +18 more
20111 citations
Semantic Scholar
Abstract 2717: Higher MN1 expression is an unfavorable prognosticator in older patients (Pts) with cytogenetically normal acute myeloid leukemia (CN-AML): A CALGB study
S. Schwind, G. Marcucci, Kelsi B. Holland, K. Mrózek +11 more
20101 citations
Semantic Scholar
Efficacy of clofarabine and low-dose cytarabine combination for genetically high-risk acute myeloid leukemia prior to allogeneic stem cell transplantation.
C. Vigil, N. Jahan, Oana Păun, J. Weis +3 more
20170 citations
Semantic Scholar
MiR-3151, a Novel MicroRNA Embedded in BAALC, Is Only Weakly Co-Expressed with Its Host Gene and Independently Impacts on the Clinical Outcome of Older Patients (Pts) with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)
Ann-Kathrin Eisfeld, G. Marcucci, K. Maharry, S. Schwind +18 more
20110 citations
Semantic Scholar
Mutations of the Wilms tumor 1 gene ( WT 1 ) in older patients with primary cytogenetically normal acute myeloid leukemia : a Cancer and Leukemia Group B study
H. Becker, G. Marcucci, K. Maharry, M. Radmacher +17 more
20100 citations
Semantic Scholar
Dendritic Cell Reconstitution Following Autologous Stem Cell Transplant with GM-CSF Support for Multiple Myeloma.
A. Schlueter, Judith K. Glasgow, W. Wilke, J. Marietta +4 more
20070 citations
Semantic Scholar
High-dose carmustine (BCNU), etoposide (VP-16), cytarabine (Ara-C), and cyclophosphamide-BVAC with autologous transplant (ASCT) in relapsed and refractory Hodgkin disease (HD): Long-term follow-up of 89 patients
T. Iyengar, M. Hayashi, C. Leopold, B. J. Smith +3 more
20070 citations
Semantic Scholar
Valganciclovir in the Prevention of Cytomegalovirus Following Allogeneic Stem Cell Transplantation.
Margarida Magalhaes-Silverma, K. Parrott, T. Carter, C. Leopold +2 more
20060 citations
Semantic Scholar
Campath-1H-Containing Reduced Intensity Regimen Followed by Unrelated Allogeneic Stem Cell Transplantation in Patients with Advanced Hematologic Malignancies.
Margarida Magalhaes-Silverma, T. Carter, A. Schlueter, R. Gingrich
20060 citations
Semantic Scholar
Vanganciclovir prophylaxis for the prevention of cytomegalovirus reactivation and disease in allogeneic stem cell transplantation recipients
M. de Magalhaes-Silverman, T. Carter, R. Hohl, H. Shamsuddin +1 more
20050 citations Open access
Semantic Scholar
Antifungal prophylaxis with voriconazole in allogeneic hematopoietic stem cell transplantation recipients
M. de Magalhaes-Silverman, T. Carter, R. Hohl, H. Shamsuddin +1 more
20050 citations Open access
Semantic Scholar
Dendritic Cell Reconstitution Following Autologous Stem Cell Transplant for Multiple Myeloma.
A. Schlueter, Judith K. Glasgow, W. Wilke, J. Marietta +4 more
20050 citations
Semantic Scholar
In vivo T cell depleted unrelated allogeneic stem cell transplantation with a reduced intensity regimen in patients with advanced hematologic malignancies
M. de Magalhaes-Silverman, T. Carter, R. Gingrich, R. Hohl +1 more
20050 citations Open access
Semantic Scholar
Zygomycosis in allogeneic hematopoietic stem cell transplant recipients receiving prophylactic voriconazole
M. de Magalhaes-Silverman, T. Carter, R. Gingrich
20040 citations
Semantic Scholar
Zygomycosis in allogeneic hematopoietic stem cell transplant recipients receiving prophylactic voriconazole.
M. de Magalhaes-Silverman, T. Carter, R. Gingrich
2004Journal of Clinical Oncology0 citations
Semantic Scholar
Marrow and stem cell transplantation in Oklahoma: fifteen years of experience and results.
R. Mandanas, T. Carter, R. Epstein, V. Roy +1 more
1998The Journal of the Oklahoma State Medical Association0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Marcucci×28
Invite
G. Marcucci — researcher profile on SciRah
K. Maharry×26
Invite
K. Maharry — researcher profile on SciRah
K. Mrózek×26
Invite
K. Mrózek — researcher profile on SciRah
H. Becker×26
Invite
H. Becker — researcher profile on SciRah

×26

Invite

S. Schwind — researcher profile on SciRah

Invite

B. Powell — researcher profile on SciRah

Invite

J. Kolitz — researcher profile on SciRah

M. Caligiuri×25

Invite

M. Caligiuri — researcher profile on SciRah

Invite

S. Whitman — researcher profile on SciRah

C. Bloomfield×24

Invite

C. Bloomfield — researcher profile on SciRah

Invite

M. Baer — researcher profile on SciRah

Invite

M. Wetzler — researcher profile on SciRah